Follistatin-344 Research Overview
Follistatin-344 is a naturally occurring activin-binding protein that functions as a myostatin antagonist in biological systems. This 344-amino acid glycoprotein represents the most abundant circulating isoform of follistatin, making it particularly valuable for researchers investigating muscle growth regulation and myostatin pathway modulation. Ultima Pharmaceuticals produces this peptide at pharmaceutical-grade purity for comprehensive laboratory research applications. Scientists at Stroid UK Shop can access this high-quality research compound for detailed molecular studies examining muscle development mechanisms.
Laboratory Research Applications
Research teams utilise Follistatin-344 to examine its role as a potent myostatin inhibitor in cell culture and tissue studies. This peptide demonstrates significant binding affinity for activin and myostatin, effectively neutralising their growth-inhibitory effects in muscle tissue models. Scientists investigate its mechanisms in promoting muscle fibre proliferation and hypertrophy through myostatin pathway blockade. The compound serves as a valuable tool for studying muscle wasting conditions, sarcopenia models, and regenerative medicine research. Laboratories examining follistatin peptide biology benefit from its well-characterised structure and consistent bioactivity profiles. Research applications extend to investigating its role in bone density regulation, adipose tissue metabolism, and reproductive biology studies where activin signalling plays crucial roles.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | ~37 kDa |
| Amino Acid Length | 344 residues |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilised powder |
| Storage | -20°C, protect from light |
| Reconstitution | Sterile water or PBS |
| Stability | 2-3 years frozen, 30 days at 4°C reconstituted |
| CAS Number | Verify with supplier |
Research institutions studying muscle biology alongside other compound classes often combine follistatin investigations with SARMs research to examine synergistic pathways in muscle development. This 1mg vial provides sufficient material for multiple experimental protocols examining dose-response relationships and temporal expression patterns. Researchers also explore connections with other peptide compounds in growth factor signalling networks.
Research Compliance Statement
Follistatin-344 peptide from Ultima Pharmaceuticals is manufactured exclusively for in-vitro research applications in licensed laboratory facilities. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must ensure proper safety protocols, waste disposal procedures, and regulatory compliance when handling this research peptide. All experimental work should be conducted by qualified personnel following institutional guidelines for peptide research compounds.
